TILT Holdings (TLLTF) Asset Writedowns and Impairment (2021 - 2025)
TILT Holdings (TLLTF) reported Asset Writedowns and Impairment of $86000.0 for Q2 2025, up 1328.57% on a YoY basis from $6020.0 in Q2 2024, and up 960.0% quarter-over-quarter from -$10000.0 in Q1 2025.
TILT Holdings (TLLTF) Asset Writedowns and Impairment (2021 - 2025) Analysis & Trends
TILT Holdings has reported Asset Writedowns and Impairment for 5 years, with the latest figure at $86000.0 in Q2 2025.
- For the quarter ending Q2 2025, Asset Writedowns and Impairment rose 1328.57% year-over-year to $86000.0; the trailing twelve-month figure through Jun 2025 stood at -$210000.0 (down 165.62% YoY), and the FY2024 full-year result was -$274000.0, down 140.47% from the prior year.
- Asset Writedowns and Impairment for Q2 2025 stood at $86000.0, up from -$10000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $349000.0 in Q4 2023, with the low at -$299000.0 in Q3 2021.
- Historically, Asset Writedowns and Impairment has averaged $3812.5 across 5 years, with a median of -$5500.0 in 2022.
- Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment soared 5575.0% — and 2024, when it tumbled 214.63%.
- TILT Holdings' Asset Writedowns and Impairment stood at $48000.0 in 2021, then fell by 4.17% to $46000.0 in 2022, then jumped by 658.7% to $349000.0 in 2023, then slumped by 144.99% to -$157000.0 in 2024, then surged by 154.78% to $86000.0 in 2025.
- The last three Asset Writedowns and Impairment figures came in at $86000.0 (Q2 2025), -$10000.0 (Q1 2025), and -$157000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | TILT Holdings | - | - | 1.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 86,000.00 |
| Jun 30, 2025 | 86,000.00 |
| Mar 31, 2025 | -10,000.00 |
| Mar 31, 2025 | -10,000.00 |
| Dec 31, 2024 | -157,000.00 |
| Dec 31, 2024 | -157,000.00 |
| Sep 30, 2024 | -129,000.00 |
| Sep 30, 2024 | -129,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Dec 31, 2023 | 349,000.00 |
| Dec 31, 2023 | 349,000.00 |
| Sep 30, 2023 | -41,000.00 |
| Sep 30, 2023 | -41,000.00 |
| Jun 30, 2023 | 219,000.00 |
| Jun 30, 2023 | 219,000.00 |
| Mar 31, 2023 | 150,000.00 |
| Mar 31, 2023 | 150,000.00 |